ARMISTICE CAPITAL, LLC's Net Worth

$711 Million

Estimate Recalculated Nov 11, 2024 02:53AM EST

Who is ARMISTICE CAPITAL, LLC?

ARMISTICE CAPITAL, LLC has an estimated net worth of $711 Million. This is based on reported shares across multiple companies, which include EYEGATE PHARMACEUTICALS INC, INNOVUS PHARMACEUTICALS, INC., ReShape Lifesciences Inc., Del Frisco's Restaurant Group, Inc., TETRAPHASE PHARMACEUTICALS INC, PAIN THERAPEUTICS INC, Vaxart, Inc., AYTU BIOSCIENCE, INC, Cyclo Therapeutics, Inc., BIO-PATH HOLDINGS INC, ReShape Lifesciences Inc., TENAX THERAPEUTICS, INC., DYNATRONICS CORP, Valeritas Holdings Inc., APRICUS BIOSCIENCES, INC., ALIMERA SCIENCES INC, VICAL INC, ACHIEVE LIFE SCIENCES, INC., Cerecor Inc., Onconova Therapeutics, Inc., and AMAG PHARMACEUTICALS INC..

SEC CIK

ARMISTICE CAPITAL, LLC's CIK is 0001601086

Past Insider Trading and Trends

2018 was ARMISTICE CAPITAL, LLC's most active year for acquiring shares with 186 total transactions. ARMISTICE CAPITAL, LLC's most active month to acquire stocks was the month of November. 2020 was ARMISTICE CAPITAL, LLC's most active year for disposing of shares, totalling 72 transactions. ARMISTICE CAPITAL, LLC's most active month to dispose stocks was the month of May. 2021 saw ARMISTICE CAPITAL, LLC paying a total of $27,463,892.73 for 19,167,767 shares, this is the most they've acquired in one year. In 2020 ARMISTICE CAPITAL, LLC cashed out on 136,903,189 shares for a total of $363,985,102.29, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EYEGATE PHARMACEUTICALS INC (KPRX) Snapshot price: $3.61

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-24.95%
-260.96K
$2.48
-$646,607.65
785K
Jul 30 - Aug 2
Form 4
-68.75%
-2.30M
$4.71
-$10,454,264.01
1.05M
Jul 27 - Jul 29
Form 4
+29.66%
1.53M
$5.23
$8,000,002.73
6.69M
Jan 6
Form 4
+0.43%
23K
$6.11
$140,460.00
5.43M
Feb 6 - Feb 10
Form 4
+9.22%
605K
$3.12
$1,890,613.11
7.16M
Sep 29 - Sep 30
Form 4
+0.79%
549.65K
$0.32
$175,216.45
70.52M
Mar 27 - Mar 29
Form 4
+0.12%
100.35K
$0.40
$40,316.08
86.21M
Dec 10 - Dec 11
Form 4
+0.43%
360K
$0.45
$161,395.09
84.97M
Nov 14 - Nov 16
Form 4
+0.09%
58.27K
$0.57
$33,432.59
67.12M
May 25 - May 29
Form 4
+0.01%
1.73K
$0.56
$959.10
33.49M
May 18
Form 4
+0.03%
15.76K
$0.53
$8,417.50
50.22M
May 14
Form 4
+0.27%
177.01K
$0.51
$90,991.63
66.78M
May 9 - May 11
Form 4
+0.12%
137.23K
$0.46
$63,472.26
115.6M
May 4 - May 8
Form 4
+0.34%
165.52K
$0.54
$89,266.30
49.16M
Apr 25 - Apr 26
Form 4
+4.21%
2.53M
$0.49
$1,231,158.70
62.74M
Apr 18 - Apr 20
Form 4/A
—
0
—
—
0
Form 4
+26.59%
10.48M
$0.36
$3,740,050.05
49.9M
Apr 13 - Apr 17
Form 3
—
0
—
—
0
No matching records found

INNOVUS PHARMACEUTICALS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-300.00K
—
—
0
Feb 14
Form 4
-100.00%
-300.00K
—
—
0
Feb 14
Form 4
+2.08%
18.18K
$2.56
$46,623.84
891K
Sep 16 - Sep 17
Form 3
—
0
—
—
0
No matching records found

ReShape Lifesciences Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-5.33M
—
—
0
Jun 15
Form 4
+0.04%
6.4K
$4.16
$26,612.00
15.99M
Dec 2 - Dec 4
Form 4
+0.01%
977
$4.21
$4,112.10
15.97M
Nov 13 - Nov 17
Form 4
+0.02%
2.4K
$3.58
$8,592.00
10.65M
Nov 10
Form 4
+0.03%
3.1K
$3.56
$11,036.00
10.64M
Nov 2
Form 4
+0.01%
2K
$4.07
$8,140.00
15.95M
Sep 23
Form 4
+0.02%
3.3K
$4.13
$13,645.00
21.26M
Sep 18 - Sep 22
Form 4
+0.00%
100
$3.75
$375.00
10.62M
Sep 14 - Sep 16
Form 4
+0.04%
10K
$3.13
$31,243.90
26.55M
Aug 18 - Aug 20
Form 4
+0.04%
4.5K
$3.00
$13,500.00
10.6M
Jul 17
Form 4
+61.74%
5.09M
$0.12
$610,300.08
13.32M
Apr 13
Form 4
—
0
—
—
0
Mar 25
Form 4
+0.48%
3K
$7.13
$21,390.00
633K
Jan 29
Form 4
+1.97%
12.05K
$5.16
$62,172.00
622.96K
Dec 19 - Dec 20
Form 4
+0.77%
3K
$5.25
$15,750.00
393.24K
Dec 16
Form 4
+0.33%
2.52K
$5.20
$13,121.95
772.58K
Dec 9 - Dec 11
Form 4
+0.20%
1.93K
$5.18
$9,997.27
953.14K
Dec 4 - Dec 6
Form 4
+0.53%
2K
$5.43
$10,860.00
378.34K
Nov 26
Form 4
+0.50%
2.79K
$5.31
$14,851.85
560.01K
Nov 20 - Nov 22
Form 4
+0.51%
3.73K
$6.78
$25,307.35
735.75K
Nov 14 - Nov 18
Form 4
+0.93%
400.64K
$3.65
$20,611.00
43.56M
Nov 11 - Nov 12
Form 4
+18.77%
6.7M
$0.02
$134,000.00
42.4M
Sep 23
Form 4
+1.38%
396.07K
$0.05
$19,803.60
29M
Sep 17
Form 4
+0.13%
53.93K
$0.07
$3,774.96
42.28M
Aug 30
Form 4
+1.44%
200K
$0.07
$14,000.00
14.05M
Aug 27 - Aug 29
Form 4
+0.85%
350K
$0.07
$25,500.00
41.45M
Aug 7 - Aug 8
Form 4
+0.95%
500K
$0.08
$39,500.00
53.25M
Jul 24 - Jul 26
Form 3
—
0
—
—
0
No matching records found

Del Frisco's Restaurant Group, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.53M
$8.00
-$52,200,000.00
0
Sep 25
Form 4
+0.20%
25K
$5.96
$149,000.00
12.25M
Jun 4
Form 4
+0.54%
65K
$4.90
$318,500.00
12.2M
May 16
Form 4
+0.50%
90K
$5.60
$504,000.00
18.07M
May 10 - May 14
Form 4
+1.10%
265K
$6.11
$1,614,150.00
24.41M
May 7 - May 9
Form 4
+0.73%
130K
$6.68
$868,000.00
17.83M
Apr 25 - Apr 30
Form 4
+0.50%
85K
$6.38
$542,150.00
17.22M
Apr 3
Form 4
+0.38%
65K
$6.39
$415,850.00
17.05M
Mar 26 - Mar 27
Form 4
+0.91%
150K
$6.43
$964,000.00
16.6M
Mar 21 - Mar 25
Form 4
+2.00%
319K
$6.42
$2,080,840.00
16.3M
Mar 18 - Mar 20
Form 4
+2.36%
571K
$7.47
$4,145,220.00
24.79M
Mar 12 - Mar 15
Form 4
+0.28%
52K
$8.19
$426,034.20
18.53M
Mar 6
Form 4
+0.25%
80K
$7.87
$632,178.10
32.42M
Jan 25 - Jan 29
Form 4
+0.96%
44.1K
$8.19
$361,314.15
4.63M
Jan 9 - Jan 11
Form 4
+1.23%
55.9K
$7.70
$430,575.34
4.58M
Jan 3 - Jan 7
Form 4
+0.38%
103K
$6.38
$657,305.20
27M
Dec 24 - Dec 27
Form 4
+1.47%
253K
$6.49
$1,641,316.17
17.5M
Dec 18 - Dec 20
Form 4
+1.48%
240K
$6.46
$1,551,512.00
16.42M
Dec 12 - Dec 14
Form 4
+0.30%
58K
$6.85
$397,267.20
19.58M
Nov 30 - Dec 4
Form 4
+0.41%
78K
$6.21
$484,229.70
19.29M
Nov 15 - Nov 16
Form 4
+0.35%
40K
$6.24
$249,678.40
11.37M
Nov 5 - Nov 7
Form 4
+0.21%
32K
$8.08
$258,431.55
15M
Sep 12
Form 3
—
0
—
—
0
No matching records found

TETRAPHASE PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.42M
—
—
0
Jul 28
Form 3
—
0
—
—
0
No matching records found